Current imaging and possible therapeutic management of glucagonoma tumors: A case report

Clinical Nuclear Medicine

Volumn 25, Issue 2, 2000, Pages 120-122

  Johnson, David Scott ^c   Coel, Marc N ^a,b   Bornemann, Michael ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b QUEEN S MEDICAL CENTER   (United States)

^c NONE

Author keywords

Glucagonoma; In 111 Octreotide; Somatostatin Receptors

Indexed keywords

GLUCAGON; OCTREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG PENETRATION; FEMALE; GLUCAGONOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; RECEPTOR BINDING;

FEMALE; GLUCAGONOMA; HUMANS; INDIUM RADIOISOTOPES; MIDDLE AGED; OCTREOTIDE; PANCREATIC NEOPLASMS; PENTETIC ACID; RADIOPHARMACEUTICALS;

EID: 0033983525     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200002000-00008     Document Type: Article

References (8)

1. Reubi JC: Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging. J Nucl Med 36:1825, 1995.
2. Haga Y, Yanagi H, Jouji U, et al: Early detection of pancreatic glucagonoma. Am J Gastroenterol 90:2216, 1995.
3. Hofland LJ, Visser-Wisselaar HA, Lamberts SW: Somatostatin analogs: Clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol 1995;50:287, 1995.
4. Gregianin M, Macri C, Bui F, et al: Whole body and tomographic scan with 111In-pentetreotide: Preliminary data. Q J Nucl Med 39(Suppl 1):124, 1995.
5. Krenning EP, Kwekkeboom DJ, Bakker WH, et al: Somatostatin receptor scintigraphy with [111In DTPA - D-Phe1]-and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716, 1993.
6. Lebtahi R, Cadiot G, Sarda L, et al: Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 38: 853, 1997.
7. Arnold R, Frank M, Kajdan U: Management of gastroenteropancreatic endocrine tumors: The place of somatostatin analogues. Digestion 55:107, 1994.
8. 3-Octreotide in tumor bearing rodents. J Nucl Med 38:18P, 1997.